METTL3 and chronic myelogenous leukemia, BCR-ABL1 positive: As METTL3 plays a significant role in normal hematopoiesis, an increasing number of studies on hematology malignancies have been reported in recent years, including AML, acute lymphocytic leukemia (ALL), CML, and lymphomas.